Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias ...Middle East

– Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in near-term milestone payments and opt-in right for solid tumors – – Companies to jointly develop and commercialize ziftomenib; 50/50 profit share in the U.S.; Kura...

Hence then, the article about kura oncology and kyowa kirin announce global strategic collaboration to develop and commercialize ziftomenib in acute leukemias was published today ( Thursday 21/11/2024 - 01:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias )

Also on site :

• Zendaya to Miss 2026 Met Gala Amid Busy Year of Releases
• Spirit Airlines Might Shut Down as Early as This Weekend, and This Is Exactly What It Means for Your Ticket
• 1972 Classic Rock Hit Was Released 54 Years Ago Today